On Strategic Choices Faced by Large Pharmaceutical Laboratories and Their Effect on Innovation Risk Under Fuzzy Conditions
Artificial Intelligence in Medicine - Netherlands
doi 10.1016/j.artmed.2019.101703
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2019
Authors
Publisher
Elsevier BV